Cancer immunotherapies: advances and bottlenecks.

Front Immunol · 2023 · PMC10484345 · PMID 37691932

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

In a phase III study, infusion with autologous tumor cell–bacillus Calmette-Guérin (BCG) vaccine after surgical resection in stage II and III colon cancer patients didn’t show statistically significant differences in clinical outcomes compared with the arm under surgical resection alone, though there was a slight trend in PFS and OS ( 72 ).

also in 2,235 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.